Our study aimed to evaluate the diagnostic utility of PRAME expression in differentiating melanoma from various melanocytic lesions, including dysplastic nevi, congenital nevi, blue nevi, and Spitz nevi. This evidence concerns the gene PRAME and spitz nevus.